Neurol. praxi. 2024;25(4):263-266 | DOI: 10.36290/neu.2024.053

CNS tumours in children - a new perspective

MUDr. Miroslav Koblížek, prof. MUDr. Josef Zámečník, Ph.D.
Ústav patologie a molekulární medicíny, 2. LF UK a FN Motol, Praha

Neuropathological diagnostics of central nervous system tumours has advanced significantly in recent years thanks to molecular biological insights and new methods such as methylation profiling. In the current WHO classification, the general approach to grading and reporting of tumours has changed as a result. New tumour groups and new units have also been created, highlighting the differences between morphologically similar tumours with different molecular pathological backgrounds. This educative article gives actual view on groups of the most frequent pediatric CNS tumours and its impact on diagnostic approaches.

Keywords: WHO classification, methylation profiling, pediatric gliomas, ependymoma, medulloblastoma.

Accepted: August 26, 2024; Published: September 10, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Koblížek M, Zámečník J. CNS tumours in children - a new perspective. Neurol. praxi. 2024;25(4):263-266. doi: 10.36290/neu.2024.053.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Capper D, Jones DTW, Sill M, et al. DNA methylation­‑based classification of central nervous system tumours. Nature. 2018;555(7697):469-474. doi:10.1038/nature26000. Go to original source... Go to PubMed...
    2. Funakoshi Y, Hata N, Kuga D, et al. Pediatric Glioma: An Update of Diagnosis, Biology, and Treatment. Cancers (Basel). 2021 Feb 12;13(4):758. doi: 10.3390/cancers13040758. Go to original source... Go to PubMed...
    3. Jirásek T, Krsková L, Dolinová I, et al. Novinky ve WHO klasifikaci nádorů centrálního nervového systému 2021. Cesk Patol. 2022;58(3):126-134.
    4. Krejci D, Zapletalova M, Svobodova I, et al. Childhood cancer epidemiology in the Czech Republic (1994-2016). Cancer Epidemiol. 2020;69:101848. doi:10.1016/j.canep.2020.101848. Go to original source... Go to PubMed...
    5. Krsková L, Šípalová B, Němečková T, et al. Efektivní schéma využívané v diagnostice nádorů CNS. Cesk Patol. 2022;58(3):135-137.
    6. Lassaletta A, Zapotocky M, Mistry M, et al. Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low­‑Grade Gliomas. J Clin Oncol. 2017;35(25):2934-2941. doi:10.1200/JCO.2016. 71. 8726. Go to original source...
    7. Louis DN, Perry A, Burger P, et al. International Society of Neuropathology - Haarlem consensus guidelines for nervous system tumor classification and grading. Brain Pathol. 2014;24(5):429-35. Go to original source... Go to PubMed...
    8. Louis DN, Perry A, Wesseling P, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 2021;23(8):1231-1251. doi:10.1093/neuonc/noab106. Go to original source... Go to PubMed...
    9. Louis DN, Wesseling P, Paulus W, et al. cIMPACT­‑NOW update 1: Not Otherwise Specified (NOS) and Not Elsewhere Classified (NEC). Acta Neuropathol. 2018;135(3):481-484. doi:10.1007/s00401-018-1808-0. Go to original source... Go to PubMed...
    10. Vícha A, Štolová L, Jenčová P, et al. Využití metylačního profilu v diagnostice a prognostice nádorových onemocnění CNS. Cesk Patol. 2021;57(3):154-160.
    11. WHO Classification of Tumours Editorial Board. World Health Organization Classification of Tumours of the Central Nervous System. 5th ed. Lyon: International Agency for Research on Cancer; 2021.

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.